Trefoil Factor 1
Introduction
Background
Trefoil factor 1 (TFF1), also known as pS2, is a small, secreted protein that is part of the trefoil factor family. These proteins are characterized by a unique 'trefoil' motif, a three-loop structure stabilized by disulfide bonds, which is crucial for their biological activity. TFF1 is predominantly found in the gastric mucosa, where it is a major component of the mucus layer, but its expression can also be observed in other epithelial tissues throughout the body.
Biological Basis
The primary biological function of TFF1 is to maintain the integrity and facilitate the repair of mucosal surfaces, particularly within the gastrointestinal tract. It acts as a cytoprotective agent by promoting the rapid migration of epithelial cells, a process known as restitution, to cover areas of damage. TFF1 is believed to interact with mucins, enhancing the physical barrier properties of the mucus layer, thereby protecting underlying cells from mechanical stress, acidic conditions, and enzymatic degradation. Its expression is often upregulated in response to injury or inflammation, underscoring its role in tissue healing and defense mechanisms.
Clinical Relevance
Alterations in TFF1 expression have been linked to several clinical conditions, most notably various forms of cancer. In some contexts, TFF1 can act as a tumor suppressor, while in others, its overexpression is associated with tumor progression and metastasis, particularly in gastric and breast cancers. For instance, TFF1 is an estrogen-responsive gene and its levels are frequently elevated in estrogen receptor-positive breast cancers, suggesting its involvement in hormone-dependent cancer development. Research also explores TFF1's potential as a diagnostic marker or a therapeutic target in these malignancies. Beyond cancer, TFF1 is relevant to inflammatory conditions of the digestive system, such as peptic ulcers and inflammatory bowel diseases, where its role in mucosal protection and repair is critical for disease resolution and patient well-being.
Social Importance
The study of TFF1 holds significant social importance due to its direct implications for human health and disease. Its fundamental role in maintaining the protective barrier of the gastrointestinal tract is crucial for preventing and healing common digestive disorders that affect a large portion of the population. Furthermore, TFF1's complex involvement in carcinogenesis, especially in prevalent cancers like gastric and breast cancer, highlights its potential as a target for new diagnostic tools and therapeutic interventions. A deeper understanding of TFF1's mechanisms could lead to improved management strategies for these diseases, ultimately enhancing quality of life and potentially extending lives for individuals affected by gastrointestinal conditions and various cancers.
Generalizability and Cohort-Specific Factors
The findings regarding genetic variants influencing serum transferrin levels, such as those in TF, are primarily derived from studies predominantly involving cohorts of white individuals of European descent, often middle-aged to elderly . It promotes cell migration and restitution, forming a critical component of the body's innate defense against environmental stressors. Variations within the TFF1 gene, such as *rs117389225* and *rs225358*, can potentially alter its expression levels or protein function, affecting the effectiveness of this protective mechanism. Similarly, GKN2 (Gastrokine 2), located in the stomach, also contributes to gastric mucosal defense and has anti-inflammatory properties, often acting as a tumor suppressor. Variants *rs62133344* and *rs62133345* in GKN2 may influence these protective functions, while *rs12990985*, found in the intergenic region between the GKN3P pseudogene and GKN2, could modulate GKN2 expression or interact with regulatory elements affecting gastric health. [1]
The integrity of mucosal surfaces also heavily relies on mucins, large glycoproteins that form a protective barrier. MUC5AC is a major gel-forming mucin produced by specialized cells in the stomach and respiratory tract, creating a physical barrier against pathogens and irritants. TFF1 often co-localizes and interacts with mucins like MUC5AC to enhance mucosal protection and facilitate healing. Variants *rs2075842* and *rs3087562* within the MUC5AC gene could impact the structure or quantity of this mucin, thereby affecting the robustness of the mucosal barrier. Furthermore, the enzyme B3GALT5 (Beta-1,3-Galactosyltransferase 5), with its variant *rs536255*, is critical for the glycosylation process, which modifies proteins and lipids . Proper glycosylation is essential for the correct folding, stability, and function of mucins and other glycoproteins, including TFF1 itself, meaning variations in B3GALT5 could indirectly influence the overall efficacy of mucosal defense systems. [2]
Other genetic factors, such as proteases and pseudogenes, can also indirectly affect the complex network of mucosal biology. TMPRSS3 (Transmembrane Serine Protease 3) is a serine protease, a type of enzyme that cleaves other proteins, and is known for its role in processes like tissue remodeling and activation of precursor proteins. Variants like *rs73225477* and *rs28653693* in TMPRSS3 might alter its enzymatic activity, potentially influencing inflammatory responses or the processing of proteins critical for mucosal maintenance. The intergenic variants *rs3761376* and *rs112214674*, located between TFF1 and TMPRSS3, may have regulatory effects on the expression of either of these genes or other nearby elements, thereby impacting their contributions to cellular health. Additionally, pseudogenes like GBA1LP (Glucosidase Beta Acid 1 Like Pseudogene), containing the variant *rs2990223*, are non-coding DNA sequences that can sometimes exert regulatory control over gene expression by acting as microRNA sponges or producing non-coding RNAs, subtly influencing cellular pathways relevant to inflammation and tissue homeostasis. [3]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs62133344 rs62133345 |
GKN2 | protein measurement blood protein amount trefoil factor 1 measurement |
| rs3761376 rs112214674 |
TFF1 - TMPRSS3 | blood protein amount protein measurement trefoil factor 1 measurement |
| rs2990223 | GBA1LP, GBA1LP | gastric carcinoma gastric adenocarcinoma Red cell distribution width cervical carcinoma, prostate carcinoma, biliary tract cancer, pancreatic carcinoma, ovarian cancer, lung cancer, colorectal cancer, breast carcinoma, hepatocellular carcinoma, non-Hodgkins lymphoma, esophageal cancer, endometrial cancer, gastric cancer trefoil factor 1 measurement |
| rs12990985 | GKN3P - GKN2 | blood protein amount trefoil factor 1 measurement protein measurement |
| rs117389225 rs225358 |
TFF1 | trefoil factor 1 measurement |
| rs2075842 rs3087562 |
MUC5AC | blood protein amount trefoil factor 1 measurement trefoil factor 2 measurement |
| rs536255 | B3GALT5 | trefoil factor 1 measurement |
| rs73225477 rs28653693 |
TMPRSS3 | trefoil factor 1 measurement |
References
[1] Benjamin, E. J. et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Med Genet, vol. 8, 2007, p. 62.
[2] Kathiresan, S. et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, vol. 40, no. 12, 2008, pp. 1414-1422.
[3] Wallace, C. et al. "Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia." Am J Hum Genet, vol. 82, no. 1, 2008, pp. 139-149.